Related references
Note: Only part of the references are listed.Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc-siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5′-exonuclease
Pawan Kumar et al.
NUCLEIC ACIDS RESEARCH (2020)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Therapeutic potential of chemically modified siRNA: Recent trends
Chelliah Selvam et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Current issues of RNAi therapeutics delivery and development
D. Haussecker
JOURNAL OF CONTROLLED RELEASE (2014)
Regiospecific Anomerisation of Acylated Glycosyl Azides and Benzoylated Disaccharides by Using TiCl4
Mark Farrell et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Single modification at position 14 of siRNA strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation
Jie Zheng et al.
FASEB JOURNAL (2013)
Steric Restrictions of RISC in RNA Interference Identified with Size-Expanded RNA Nucleobases
Armando R. Hernandez et al.
ACS CHEMICAL BIOLOGY (2012)
siRNA-optimized Modifications for Enhanced In Vivo Activity
Denise M. Kenski et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering
Jesper B. Bramsen et al.
Frontiers in Genetics (2012)
Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf
Michael Fisher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Circular dichroism and conformational polymorphism of DNA
Jaroslav Kypr et al.
NUCLEIC ACIDS RESEARCH (2009)
Chemically modified siRNA: tools and applications
Jonathan K. Watts et al.
DRUG DISCOVERY TODAY (2008)
Structural characterization and biological evaluation of small interfering RNAs containing cyclohexenyl nucleosides
Koen Nauwelaerts et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Inhibition of MDR1 expression with altritol-modified siRNAs
Michael Fisher et al.
NUCLEIC ACIDS RESEARCH (2007)
Stability of 3' double nucleotide overhangs that model the 3' ends of siRNA
AS O'Toole et al.
RNA (2005)
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
J Elmen et al.
NUCLEIC ACIDS RESEARCH (2005)
RNA interference: Biology, mechanism, and applications
N Agrawal et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
siRNA function in RNAi: A chemical modification analysis
YL Chiu et al.
RNA (2003)
RNA interference in mammalian cells by chemically-modified RNA
DA Braasch et al.
BIOCHEMISTRY (2003)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Share Paper
